STEC infection is a gastrointestinal illness caused by Escherichia coli that releases Shiga toxins, and it is the typical precipitating infection for hemolytic uremic syndrome [1][3]. The infection is confirmed by biological screening for Shiga toxins and STEC in stool specimens [1].
Aperçu de la maladie
BactérienneE. coli vérotoxique
Shiga toxin-producing Escherichia coli infection
Suivre cette maladie Comparer les paysShiga toxin-producing Escherichia coli (STEC) infection is a leading cause of hemolytic uremic syndrome in children and carries substantial outbreak potential [1]. Since the early 2010s, its epidemiology has shifted from predominant O157 to emerging non-O157 serogroups such as O26 and O80 in France [1]. Antibiotics are not recommended in STEC-infected individuals based on meta-analytic evidence [2].
Lire le profil clinique et épidémiologique complet 6
The principal manifestation is diarrhea, which is bloody in roughly 60% of cases and begins after a median incubation of three days [1]. Released Shiga toxins trigger thrombogenic and inflammatory injury to microvascular endothelial cells [1]. Hemolytic uremic syndrome develops in 5–15% of infections and is marked by mechanical hemolytic anemia, thrombocytopenia, and acute renal injury [1].
STEC infection exhibits major outbreak potential and is the foremost cause of HUS in children [1]. From the early 2010s onward, a decline of the historically dominant O157 serogroup and rise of non-O157 types, particularly O26 and O80, have been observed in France [1].
Human infection occurs through ingestion of contaminated food or water, person-to-person spread, or contact with ruminants and their contaminated environments [1].
Use of antibiotics in STEC-infected persons is not recommended, as pooled low-bias evidence linked treatment to a significantly increased odds of HUS development [2]. Preclinical investigation in mice indicates that cashew gum-derived fractions can reduce STEC colonization and protect intestinal mucosa, though human preventive application remains unestablished [4].
- 1 Bruyand M et al. Hemolytic uremic syndrome due to Shiga toxin-producing Escherichia coli infection. Med Mal Infect. 2018 May. PMID: 29054297. doi: 10.1016/j.medmal.2017.09.012. PubMed: https://pubmed.ncbi.nlm.nih.gov/29054297/
- 2 Freedman SB et al. Shiga Toxin-Producing Escherichia coli Infection, Antibiotics, and Risk of Developing Hemolytic Uremic Syndrome: A Meta-analysis. Clin Infect Dis. 2016 May 15. PMID: 26917812. doi: 10.1093/cid/ciw099. PubMed: https://pubmed.ncbi.nlm.nih.gov/26917812/
- 3 Jokiranta TS et al. HUS and atypical HUS. Blood. 2017 May 25. PMID: 28416508. doi: 10.1182/blood-2016-11-709865. PubMed: https://pubmed.ncbi.nlm.nih.gov/28416508/
- 4 Chaves LS et al. Cashew gum fractions protect intestinal mucosa against shiga toxin-producing Escherichia coli infection: Characterization and insights into microbiota modulation. Int J Biol Macromol. 2025 Jun. PMID: 40324507. doi: 10.1016/j.ijbiomac.2025.143916. PubMed: https://pubmed.ncbi.nlm.nih.gov/40324507/
- A04.3
- 1A03
Chargement des données actuelles…
Tendances nationales
Choisissez le pays, la source et la mesure ; chaque courbe conserve sa période et sa définition de déclaration.
Couverture des données
Pays et régions déclarants
La carte montre la couverture déclarée. Choisissez une mesure ou ouvrez un lieu coloré pour consulter ses données.
Chargement des données actuelles…
Profil de surveillance
Saisonnalité du pays sélectionné
Consultez les valeurs mensuelles d’un pays par année. Les cases vides indiquent une valeur non publiée.
Chargement des alertes officielles…
Téléchargement et méthodes
Choisissez une période et téléchargez les fichiers CSV, JSON ou XLSX.

